Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	250,591	229,409	177,678	173,698	203,518	226,045	Upgrade
Market Cap Growth	23.09%	29.12%	2.29%	-14.65%	-9.97%	-6.71%	Upgrade
Last Close Price	3.63	2.84	2.01	1.88	2.00	1.97	Upgrade
PE Ratio	6.60	5.85	4.48	3.84	4.30	5.34	Upgrade
PS Ratio	2.46	2.28	1.73	1.52	1.69	2.22	Upgrade
PB Ratio	0.40	0.37	0.29	0.30	0.34	0.42	Upgrade
P/FCF Ratio	170.35	-	-	-	-	1.73	Upgrade
P/OCF Ratio	21.63	-	-	-	-	1.62	Upgrade
Debt / Equity Ratio	2.94	2.84	2.74	2.48	2.41	2.01	Upgrade
Debt / FCF Ratio	1263.38	-	-	-	-	8.30	Upgrade
Return on Equity (ROE)	7.25%	7.32%	7.71%	9.06%	9.29%	9.02%	Upgrade
Return on Assets (ROA)	0.59%	0.61%	0.63%	0.74%	0.77%	0.75%	Upgrade
Earnings Yield	15.15%	19.34%	25.29%	29.16%	26.18%	19.88%	Upgrade
FCF Yield	0.59%	-99.36%	-5.44%	-39.74%	-70.93%	57.95%	Upgrade
Dividend Yield	5.66%	7.09%	9.49%	11.42%	12.33%	12.67%	Upgrade
Payout Ratio	54.53%	36.27%	39.34%	34.97%	37.20%	35.55%	Upgrade
Buyback Yield / Dilution	5.29%	0.37%	2.54%	-0.63%	-0.68%	-0.51%	Upgrade
Total Shareholder Return	10.95%	7.46%	12.03%	10.79%	11.65%	12.15%	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.